CDC42 and neoplasm: Although the Rac1 and Cdc42 oncogenes have been showed to promote carcinogenesis progression and angiogenesis, and to play critical roles in VEGF-dependent tumor angiogenesis [11]–[15], comprehensive clinical data and the specific mechanisms of Rac1/Cdc42-mediated tumor angiogenesis require further investigation.